{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:11:47Z","timestamp":1790795507252,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.humpath.2026.106198","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:44:37Z","timestamp":1780555477000},"page":"106198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Practical approaches to the diagnosis and differential diagnosis of T-lymphoblastic leukemia\/lymphoma"],"prefix":"10.1016","author":[{"given":"Wei J.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph D.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-4556","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2026.106198_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2014-10-551895","article-title":"How I treat T-cell acute lymphoblastic leukemia in adults","volume":"126","author":"Litzow","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1200\/JCO.2015.64.7156","article-title":"When to treat adults like children: optimizing therapy for lymphoblastic lymphoma in young adults","volume":"34","author":"O'Dwyer","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2026.106198_bib3","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2026.106198_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.humpath.2012.02.007","article-title":"The spectrum of lymphoblastic, nodal and extranodal T-cell lymphomas: characteristic features and diagnostic dilemmas","volume":"44","author":"Savage","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1309\/AJCPMF03LVSBLHPJ","article-title":"T-lymphoblastic leukemia\/lymphoma","volume":"144","author":"You","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib6","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(91)70302-I","article-title":"Lymphoblastic lymphoma presenting in cutaneous sites. A clinicopathologic analysis of six cases","volume":"25","author":"Sander","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.humpath.2026.106198_bib7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1097\/PAS.0b013e318165eb50","article-title":"Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms","volume":"32","author":"Talwalkar","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib8","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.blre.2019.04.003","article-title":"Mechanisms of extramedullary relapse in acute lymphoblastic leukemia: reconciling biological concepts and clinical issues","volume":"36","author":"Gaudichon","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.humpath.2026.106198_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1365-2141.1997.d01-2171.x","article-title":"Morphological and cytochemical findings in 150 cases of T-lineage acute lymphoblastic leukaemia in adults. German multicentre ALL study group (GMALL)","volume":"97","author":"Gassmann","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib10","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1002\/1097-0142(19811201)48:11<2347::AID-CNCR2820481102>3.0.CO;2-X","article-title":"Lymphoblastic lymphoma: a clinicopathologic study of 95 patients","volume":"48","author":"Nathwani","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2026.106198_bib11","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/PAP.0000000000000249","article-title":"Primary mediastinal nodal and extranodal non-hodgkin lymphomas: current concepts, historical evolution, and useful diagnostic approach: part 1","volume":"26","author":"Pina-Oviedo","year":"2019","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib12","series-title":"Flow cytometry in Hematolymphoid Neoplasms","author":"Wang","year":"2026"},{"key":"10.1016\/j.humpath.2026.106198_bib13","doi-asserted-by":"crossref","first-page":"16268","DOI":"10.1073\/pnas.0407359101","article-title":"Crystal structure of a human CD3-epsilon\/delta dimer in complex with a UCHT1 single-chain antibody fragment","volume":"101","author":"Arnett","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106198_bib14","doi-asserted-by":"crossref","first-page":"7675","DOI":"10.1073\/pnas.0402295101","article-title":"Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3","volume":"101","author":"Kjer-Nielsen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.humpath.2026.106198_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ajcp\/aqaa086","article-title":"Cytoplasmic expression of CD3epsilon heterodimers by flow cytometry rapidly distinguishes between mature T-Cell and natural killer-cell neoplasms","volume":"154","author":"Shi","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1182\/blood.2019004434","article-title":"Microgranular acute promyelocytic leukemia with expression of T-cell markers mimicking mixed-phenotype acute leukemia","volume":"135","author":"Liu","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12308-018-0329-z","article-title":"High-risk acute promyelocytic leukemia with unusual T\/Myeloid immunophenotype successfully treated with ATRA and arsenic trioxide-based regimen","volume":"11","author":"Singh","year":"2018","journal-title":"J Hematop"},{"key":"10.1016\/j.humpath.2026.106198_bib18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.leukres.2018.05.009","article-title":"Cytoplasmic CD3 expression in infant acute megakaryoblastic leukemia: a new ambiguous lineage subtype?","volume":"71","author":"Rossi","year":"2018","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106198_bib19","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/10428194.2022.2140285","article-title":"Frequent detection of CBFA2T3::GLIS2 fusion and RAM-Phenotype in pediatric non-down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression","volume":"64","author":"Chen","year":"2023","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2026.106198_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.humpath.2021.05.007","article-title":"CD2 and CD7 are sensitive flow cytometry screening markers for T-lineage acute leukemia(s): a study of 465 acute leukemia cases","volume":"114","author":"Rozenova","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052002","article-title":"Analysis of antigen expression in T-Cell acute lymphoblastic leukemia by multicolor flow cytometry: implications for the detection of measurable residual disease","volume":"26","author":"Semchenkova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.humpath.2026.106198_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1386132","article-title":"Exploitation of CD3zeta to enhance TCR expression levels and antigen-specific T cell function","volume":"15","author":"Degirmencay","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cyto.b.70020","article-title":"Mature T-cell leukemia\/lymphoma with an NK-like immunophenotype: a report of 7 cases","author":"Wang","year":"2026","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2026.106198_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1188063","article-title":"Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.humpath.2026.106198_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1126\/science.1188989","article-title":"An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b","volume":"329","author":"Li","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.humpath.2026.106198_bib26","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1038\/leu.2017.70","article-title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation","volume":"31","author":"Ha","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/s41590-018-0238-4","article-title":"Bcl11b sets pro-T cell fate by site-specific cofactor recruitment and by repressing Id2 and Zbtb16","volume":"19","author":"Hosokawa","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib28","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","article-title":"Transcriptional drivers of the T-cell lineage program","volume":"24","author":"Rothenberg","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.669498","article-title":"Epigenetic dynamics in the function of T-Lineage regulatory factor Bcl11b","volume":"12","author":"Sidwell","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.pathol.2022.04.012","article-title":"Expression pattern and diagnostic utility of BCL11B in mature T- and NK-cell neoplasms","volume":"54","author":"Fang","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106198_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc9801","article-title":"The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation","volume":"6","author":"Holmes","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib32","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.pathol.2025.01.010","article-title":"BCL11B helps to define T-lineage in lymphomas\/leukaemias with a mixed\/ambiguous immunophenotype","volume":"57","author":"E","year":"2025","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106198_bib33","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/bjh.17681","article-title":"B-cell lymphoma\/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia\/lymphoma (ETP-ALL\/LBL) from other subtypes of T-cell ALL\/LBL","volume":"194","author":"Fang","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13073-019-0681-3","article-title":"Immune receptor repertoires in pediatric and adult acute myeloid leukemia","volume":"11","author":"Zhang","year":"2019","journal-title":"Genome Med"},{"key":"10.1016\/j.humpath.2026.106198_bib35","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.1007\/s00277-025-06687-2","article-title":"Frequent TCR rearrangements in pediatric B-cell lymphoblastic acute leukemia: genomic and phenotypic features","volume":"104","author":"Zheng","year":"2025","journal-title":"Ann Hematol"},{"key":"10.1016\/j.humpath.2026.106198_bib36","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.leukres.2005.11.007","article-title":"The incidence of T-cell receptor gene rearrangements in childhood B-lineage acute lymphoblastic leukemia is related to immunophenotype and fusion oncogene expression","volume":"30","author":"Meleshko","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106198_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2404590","article-title":"Prevalence and clinical association of clonal T-cell expansions in myelodysplastic syndrome","volume":"21","author":"Epling-Burnette","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.659625","article-title":"Response to hypomethylating agents in myelodysplastic syndrome is associated with emergence of novel TCR clonotypes","volume":"12","author":"Abbas","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib39","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clml.2019.12.021","article-title":"High incidence of clonal CD8+ T-cell proliferation in non-malignant conditions May reduce the significance of T-cell clonality assay for differential diagnosis in oncohematology","volume":"20","author":"Sidorova","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2026.106198_bib40","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.4049\/jimmunol.154.7.3538","article-title":"Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis","volume":"154","author":"Fitzgerald","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.humpath.2026.106198_bib41","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/sj.leu.2403981","article-title":"IgH\/TCR rearrangements are common in MLL translocated adult AML and suggest an early T\/myeloid or B\/myeloid maturation arrest, which correlates with the MLL partner","volume":"19","author":"Dupret","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.leu.2401277","article-title":"Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease","volume":"13","author":"Szczepanski","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib43","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106198_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s40364-021-00347-z","article-title":"Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick","volume":"9","author":"Tarantini","year":"2021","journal-title":"Biomark Res"},{"key":"10.1016\/j.humpath.2026.106198_bib45","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106198_bib46","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/j.seminhematol.2018.05.008","article-title":"Molecular assessment of clonality in lymphoid neoplasms","volume":"56","author":"Wang","year":"2019","journal-title":"Semin Hematol"},{"key":"10.1016\/j.humpath.2026.106198_bib47","first-page":"35","article-title":"Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia","volume":"7","author":"Pui","year":"1993","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib48","first-page":"967","article-title":"Clinical relevance of CD10 expression in childhood ALL. The Italian association for pediatric hematology and oncology (AIEOP)","volume":"83","author":"Consolini","year":"1998","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106198_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/cyto.b.22242","article-title":"A 20-color 21-antigen flow cytometric assay for disease monitoring of T-cell lymphoblastic leukemia","volume":"108","author":"Gao","year":"2025","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2026.106198_bib50","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V99.2.627","article-title":"Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10","volume":"99","author":"Attygalle","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib51","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/PAS.0000000000001315","article-title":"Application of a 5 marker panel to the routine diagnosis of peripheral T-Cell lymphoma with T-Follicular helper phenotype","volume":"43","author":"Basha","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib52","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/01.MP.0000084630.64243.D1","article-title":"Benign CD10-positive T cells in reactive lymphoid proliferations and B-cell lymphomas","volume":"16","author":"Cook","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib53","first-page":"277","article-title":"013 (CD99) positivity in hematologic proliferations correlates with TdT positivity","volume":"10","author":"Robertson","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/sj.leu.2403303","article-title":"CD99 expression in T-lineage ALL: implications for flow cytometric detection of minimal residual disease","volume":"18","author":"Dworzak","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaj2025","article-title":"CD99 is a therapeutic target on disease stem cells in myeloid malignancies","volume":"9","author":"Chung","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.humpath.2026.106198_bib56","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3324\/haematol.2018.207001","article-title":"Clinical and preclinical characterization of CD99 isoforms in acute myeloid leukemia","volume":"105","author":"Vaikari","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106198_bib57","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/blood.2020005020","article-title":"Peripheral T-cell lymphoma, NOS, with rapidly progressing leukocytosis mimicking acute lymphoblastic leukemia","volume":"135","author":"Jelinek","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib58","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cyto.b.21833","article-title":"Applications of flow cytometric immunophenotyping in the diagnosis and posttreatment monitoring of B and T lymphoblastic leukemia\/lymphoma","volume":"96","author":"DiGiuseppe","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2026.106198_bib59","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/cyto.a.24805","article-title":"FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: an AIEOP-BFM-ALL-FLOW study group report","volume":"105","author":"Kowarsch","year":"2024","journal-title":"Cytometry A"},{"key":"10.1016\/j.humpath.2026.106198_bib60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.humpath.2026.106198_bib61","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/CMAR.S196574","article-title":"T-lymphoid\/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with NOTCH1 mutation as a good prognostic factor","volume":"11","author":"Noronha","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.humpath.2026.106198_bib62","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.humpath.2026.106198_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The genetic basis and cell of origin of mixed phenotype acute leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106198_bib64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bjh.15129","article-title":"Acute myeloid\/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy","volume":"180","author":"Gutierrez","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib65","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41375-020-0965-z","article-title":"A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis","volume":"35","author":"Bond","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib66","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib67","first-page":"2275","article-title":"The international consensus classification of acute leukemias of ambiguous lineage","volume":"141","author":"Weinberg","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib68","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cyto.b.21072","article-title":"A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin","volume":"84","author":"van den Ancker","year":"2013","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.humpath.2026.106198_bib69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/bjh.12277","article-title":"Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia","volume":"161","author":"Guy","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib70","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bjh.17210","article-title":"Standardised immunophenotypic analysis of myeloperoxidase in acute leukaemia","volume":"193","author":"Bras","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib71","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib72","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjh.15425","article-title":"Genetic characterization and therapeutic targeting of MYC-Rearranged T cell acute lymphoblastic leukaemia","volume":"185","author":"Milani","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2026.106198_bib73","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1097\/MPH.0000000000002967","article-title":"Pediatric T-lymphoblastic leukemia with an entirely mature immunophenotype: a prompt and challenging diagnosis","volume":"47","author":"Cheng","year":"2025","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.humpath.2026.106198_bib74","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","article-title":"The genomic basis of childhood T-lineage acute lymphoblastic leukaemia","volume":"632","author":"Polonen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2026.106198_bib75","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.humpath.2026.106198_bib76","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations","volume":"124","author":"La","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib77","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288233","article-title":"The immunophenotypic and genetic characterization of pediatric T -L ymphoblastic leukemia with a mature immunophenotype","author":"Khanlari","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106198_bib78","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.2019000402","article-title":"Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia","volume":"134","author":"Staber","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib79","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/ajcp\/aqac166","article-title":"T-Cell prolymphocytic leukemia with t(X;14)(q28;q11.2): a clinicopathologic study of 15 cases","volume":"159","author":"Hu","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib80","doi-asserted-by":"crossref","DOI":"10.1093\/ajcp\/aqae075","article-title":"Morphology, immunophenotype, and suggested diagnostic criteria of TCL1 family-negative T-prolymphocytic leukemia","author":"Fang","year":"2024","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib81","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41375-023-01956-3","article-title":"T-prolymphocytic leukemia: TCL1 or MTCP1 rearrangement is not mandatory to establish diagnosis","volume":"37","author":"Fang","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib82","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.clml.2014.02.009","article-title":"Leukemic phase of ALK(+) anaplastic large-cell lymphoma, small-cell variant: clinicopathologic pitfalls of a rare entity","volume":"14","author":"Ok","year":"2014","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.humpath.2026.106198_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.humpath.2024.105671","article-title":"Systemic ALK-Negative anaplastic large cell lymphoma: insights into morphologic, immunophenotypic, genetic and molecular characteristics","volume":"156","author":"Xie","year":"2025","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-022-03402-8","article-title":"Updates on eosinophilic disorders","volume":"482","author":"Tzankov","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2026.106198_bib85","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13256-022-03722-y","article-title":"Myeloid\/lymphoid neoplasm with eosinophilia and BCR\/FGFR1 rearrangement with transformation to cortical T-lymphoblastic lymphoma and erythroid precursors: a case report","volume":"17","author":"Isaza","year":"2023","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.humpath.2026.106198_bib86","article-title":"Myeloid\/lymphoid neoplasm with ZMYM2::FGFR1 rearrangement: a complex trilineage phenotypic and clonal evolution with associated genomic alterations","volume":"19","author":"Chen","year":"2023","journal-title":"Leuk Res Rep"},{"key":"10.1016\/j.humpath.2026.106198_bib87","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/s41379-021-00817-7","article-title":"Myeloid\/lymphoid neoplasms with FLT3 rearrangement","volume":"34","author":"Tang","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106460","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and FLT3 rearrangement","volume":"99","author":"Shao","year":"2020","journal-title":"Leuk Res"},{"key":"10.1016\/j.humpath.2026.106198_bib89","article-title":"Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia","volume":"2014","author":"Xu","year":"2014","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.humpath.2026.106198_bib90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/hematolrep16030040","article-title":"A rare onset of T-Lymphoid blast crisis in chronic myeloid leukemia with two distinct blast populations","volume":"16","author":"Mongia","year":"2024","journal-title":"Hematol Rep"},{"key":"10.1016\/j.humpath.2026.106198_bib91","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcp\/aqae115","article-title":"Blast phase of chronic myeloid leukemia presenting as early T-cell precursor acute lymphoblastic leukemia","volume":"163","author":"E","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib92","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41375-023-01958-1","article-title":"Myeloid\/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort","volume":"37","author":"Metzgeroth","year":"2023","journal-title":"Leukemia"},{"key":"10.1016\/j.humpath.2026.106198_bib93","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.path.2025.08.008","article-title":"Blastic plasmacytoid dendritic cell neoplasm: updates in diagnostic and molecular pathology","volume":"19","author":"Griffin","year":"2026","journal-title":"Surg Pathol Clin"},{"key":"10.1016\/j.humpath.2026.106198_bib94","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3324\/haematol.2020.247569","article-title":"Immunophenotypic characterization of reactive and neoplastic plasmacytoid dendritic cells permits establishment of a 10-color flow cytometric panel for initial workup and residual disease evaluation of blastic plasmacytoid dendritic cell neoplasm","volume":"106","author":"Wang","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2026.106198_bib95","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1097\/PAS.0000000000001316","article-title":"Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm","volume":"43","author":"Sukswai","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib96","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ajh.23567","article-title":"TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow","volume":"88","author":"Alayed","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2026.106198_bib97","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/his.12405","article-title":"Utility of PAX8 mouse monoclonal antibody in the diagnosis of thyroid, thymic, pleural and lung tumours: a comparison with polyclonal PAX8 antibody","volume":"65","author":"Toriyama","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2026.106198_bib98","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1182\/blood.2023022586","article-title":"Thymoma with aberrant expression of CD20: a potential diagnostic pitfall of B-cell lymphoma","volume":"143","author":"Wei","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2026.106198_bib99","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jclinpath-2018-205399","article-title":"Distinguishing thymoma from T-lymphoblastic leukaemia\/lymphoma: a case-based evaluation","volume":"72","author":"Boddu","year":"2019","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1309\/K2FY1TED8GEGFLNG","article-title":"Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia\/lymphoblastic lymphoma","volume":"121","author":"Li","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib101","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ajcp\/aqv024","article-title":"LMO2 is a specific marker of T-Lymphoblastic leukemia\/lymphoma","volume":"145","author":"Jevremovic","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib102","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/ijlh.13873","article-title":"Indolent T-lymphoblastic proliferation: a systematic review of the literature analyzing the epidemiologic, clinical, and pathologic features of 45 cases","volume":"44","author":"Saglam","year":"2022","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.humpath.2026.106198_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2025.152573","article-title":"From the archives of MD anderson cancer center: stroma-Rich hyaline vascular castleman disease followed by indolent T-lymphoblastic proliferation and detection of PDGFRB mutation","volume":"80","author":"Al-Rusan","year":"2026","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.humpath.2026.106198_bib104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.pathol.2017.09.017","article-title":"Indolent T-lymphoblastic proliferation associated with low grade follicular dendritic cell sarcoma and castleman disease","volume":"50","author":"Quesada","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2026.106198_bib105","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/cyto.b.21845","article-title":"Flow cytometric features of incidental indolent T lymphoblastic proliferations","volume":"98","author":"Fromm","year":"2020","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004681772600167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:33:01Z","timestamp":1780975981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004681772600167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":105,"alternative-id":["S004681772600167X"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106198","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical approaches to the diagnosis and differential diagnosis of T-lymphoblastic leukemia\/lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2026.106198","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106198"}}